Once that was done, I was connected to a provider who asked the same questions, then told me that she would approve my order
In summary, early research suggests TUDCA can improve insulin sensitivity, but the evidence is limited to short-term studies, so its role in metabolic health remains uncertain
These results follow similar findings from the companys ATTAIN-1 trial released earlier this month, which tested the drug on people who were overweight or obese without type 2 diabetes (in general, people without diabetes tend to lose more weight from GLP-1 therapy than those with diabetes)
You will need a diagnosis of type 2 diabetes, hypertension, high cholesterol, cardiovascular disease, or sleep apnea to qualify
Severe allergic reactions, such as itching or difficulty breathing, are rare but possible